home / stock / qure / qure short
Short Information | uniQure N.V. (NASDAQ:QURE)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,537,097 |
Total Actual Volume | 10,863,713 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 76,855 |
Average Short Percentage | 14.54% |
Is there a QURE Short Squeeze or Breakout about to happen?
See the QURE Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $4.43 | $4.01 | $4.43 | $3.94 | 1,124,365 | 268,382 | 23.87% |
07-01-2024 | $4.44 | $4.445 | $4.58 | $4.375 | 463,764 | 86,622 | 18.68% |
06-28-2024 | $4.5 | $4.48 | $4.58 | $4.31 | 435,444 | 89,051 | 20.45% |
06-27-2024 | $4.43 | $4.54 | $4.56 | $4.32 | 372,573 | 23,537 | 6.32% |
06-26-2024 | $4.49 | $4.4 | $4.49 | $4.365 | 504,285 | 78,656 | 15.6% |
06-25-2024 | $4.5 | $4.46 | $4.54 | $4.43 | 394,192 | 55,684 | 14.13% |
06-24-2024 | $4.55 | $4.54 | $4.62 | $4.38 | 469,463 | 79,078 | 16.84% |
06-21-2024 | $4.6 | $4.59 | $4.78 | $4.53 | 459,197 | 65,178 | 14.19% |
06-20-2024 | $4.51 | $4.56 | $4.6 | $4.42 | 431,020 | 119,435 | 27.71% |
06-18-2024 | $4.65 | $4.57 | $4.67 | $4.515 | 609,003 | 137,350 | 22.55% |
06-17-2024 | $4.89 | $4.69 | $4.89 | $4.65 | 607,368 | 64,367 | 10.6% |
06-14-2024 | $5.2 | $4.89 | $5.2 | $4.86 | 541,461 | 67,963 | 12.55% |
06-13-2024 | $5.26 | $5.25 | $5.34 | $5.2 | 318,867 | 63,479 | 19.91% |
06-12-2024 | $5.41 | $5.28 | $5.49 | $5.205 | 376,016 | 34,873 | 9.27% |
06-11-2024 | $5.33 | $5.23 | $5.36 | $5.07 | 524,896 | 67,451 | 12.85% |
06-10-2024 | $5.28 | $5.38 | $5.43 | $5.182 | 414,433 | 47,217 | 11.39% |
06-07-2024 | $5.23 | $5.33 | $5.35 | $5.15 | 451,721 | 31,414 | 6.95% |
06-06-2024 | $5.44 | $5.31 | $5.44 | $5.29 | 324,131 | 54,681 | 16.87% |
06-05-2024 | $5.44 | $5.43 | $5.59 | $5.26 | 1,021,561 | 35,730 | 3.5% |
06-04-2024 | $5.27 | $5.42 | $5.62 | $5.19 | 1,019,953 | 66,949 | 6.56% |
News, Short Squeeze, Breakout and More Instantly...
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA PR Newswire Strategic acquisition will enable Genezen to deliver late-phase and commercial gene therapy development and manufacturing services to customers around the world. ...
~ Proposed divestiture streamlines uniQure’s focus and represents an important milestone in its ongoing effort to significantly reduce operating expenses ~ ~ Genezen to manufacture global commercial supply of HEMGENIX ® and support uniQure’s pipeline progr...
~ Designation based on 24-month interim Phase I/II clinical data for AMT-130 announced in December 2023 ~ ~ AMT-130 is the first therapeutic candidate to receive RMAT Designation for Huntington’s disease ~ ~ Receiving RMAT designation enables increased collaboration with ...